These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 347640

  • 1. Immune response to tumour antigens.
    McConnell I.
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):381-4. PubMed ID: 347640
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Tumour immunology (author's transl)].
    Sellin D.
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():341-9. PubMed ID: 88727
    [Abstract] [Full Text] [Related]

  • 5. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH, Gurish MF, Daynes RA.
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [Abstract] [Full Text] [Related]

  • 6. Identification of tumour rejection antigens recognized by T lymphocytes.
    Boon T, De Plaen E, Lurquin C, Van den Eynde B, van der Bruggen P, Traversari C, Amar-Costesec A, Van Pel A.
    Cancer Surv; 1992 Sep; 13():23-37. PubMed ID: 1423324
    [Abstract] [Full Text] [Related]

  • 7. Dissection of tumour-specific antigenicity.
    Wortzel RD, Stauss HJ, Van Waes C, Schreiber H.
    Cancer Surv; 1985 Sep; 4(1):115-34. PubMed ID: 3879854
    [Abstract] [Full Text] [Related]

  • 8. Lessons from T cell responses to virus induced tumours for cancer eradication in general.
    Melief CJ, Kast WM.
    Cancer Surv; 1992 Sep; 13():81-99. PubMed ID: 1423326
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients.
    Purtilo DT, Manolov G, Manolova Y, Harada S, Lipscomb H.
    IARC Sci Publ; 1984 Sep; (63):749-70. PubMed ID: 6100288
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy.
    Oliver RT, Nouri AM.
    Cancer Surv; 1992 Sep; 13():173-204. PubMed ID: 1423323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Immunotherapy of malignant growths (author's transl)].
    Gericke D.
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():350-7. PubMed ID: 88728
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.